Abstract

In eukaryotes, the carboxy-terminal domain (CTD) of the largest subunit of RNA polymerase II (Pol II) is composed of tandem repeats of the heptapeptide YSPTSPS, which is subjected to reversible phosphorylation at Ser2, Ser5, and Ser7 during the transcription cycle. Dynamic changes in CTD phosphorylation patterns, established by the activities of multiple kinases and phosphatases, are responsible for stage-specific recruitment of various factors involved in RNA processing, histone modification, and transcription elongation/termination. Yeast Ssu72, a CTD phosphatase specific for Ser5 and Ser7, functions in 3′-end processing of pre-mRNAs and in transcription termination of small non-coding RNAs such as snoRNAs and snRNAs. Vertebrate Ssu72 exhibits Ser5- and Ser7-specific CTD phosphatase activity in vitro, but its roles in gene expression and CTD dephosphorylation in vivo remain to be elucidated. To investigate the functions of vertebrate Ssu72 in gene expression, we established chicken DT40 B-cell lines in which Ssu72 expression was conditionally inactivated. Ssu72 depletion in DT40 cells caused defects in 3′-end formation of U2 and U4 snRNAs and GAPDH mRNA. Surprisingly, however, Ssu72 inactivation increased the efficiency of 3′-end formation of non-polyadenylated replication-dependent histone mRNA. Chromatin immunoprecipitation analyses revealed that Ssu72 depletion caused a significant increase in both Ser5 and Ser7 phosphorylation of the Pol II CTD on all genes in which 3′-end formation was affected. These results suggest that vertebrate Ssu72 plays positive roles in 3′-end formation of snRNAs and polyadenylated mRNAs, but negative roles in 3′-end formation of histone mRNAs, through dephosphorylation of both Ser5 and Ser7 of the CTD.

Highlights

  • In eukaryotes, all protein-coding genes and many non-coding RNA genes are transcribed by RNA polymerase II (Pol II), which consists of 12 subunits

  • Amplified two genomic DNA fragments, a 2 kb region upstream of the first exon of the Ssu72 gene (ENSGALG00000001489) and a 3.9 kb region downstream of the second exon, and cloned these fragments into the flanking regions of drug-resistance cassettes (Fig. 1A). These knockout constructs were sequentially introduced into a parental DT40 cell line that stably expresses the Tet repressor fused to the herpes simplex virus VP16 activation domain, as well as a chicken Ssu72 transgene under control of the tetracycline-repressive promoter (Ssu72+/+/FLAG-Ssu72)

  • Using the mutant DT40 cell lines, we investigated whether Ssu72 inactivation affects 39-end formation of two types of Pol II transcripts, poly(A)-containing mRNA and spliceosomal snRNA, whose 39 ends are formed by distinct mechanisms (Fig. 4A) [5]

Read more

Summary

Introduction

All protein-coding genes and many non-coding RNA genes are transcribed by RNA polymerase II (Pol II), which consists of 12 subunits. Ssu was shown to be a subunit of cleavage and polyadenylation factor (CPF) holo-complex that is involved in 39-end processing of some pre-mRNAs and in transcription termination of small noncoding RNAs such as snoRNAs, snRNAs, and cryptic unstable transcripts (CUTs) [18,19,20,21,22]. Recent studies demonstrated that human Ssu, like its yeast counterpart, exhibits Ser5P and Ser7P-specific CTD phosphatase activity in vitro [27,28], its in vivo roles in CTD dephosphorylation and gene expression remain to be elucidated. Ssu depletion caused a significant increase in both Ser and Ser phosphorylation on all genes in which 39-end processing was affected These results suggest that vertebrate Ssu plays positive roles in 39-end formation of snRNAs and polyadenylated mRNAs, but a negative role in 39-end formation of histone mRNAs, by dephosphorylating both Ser5P and Ser7P of the RNA Pol II CTD

Results
Discussion
Experimental Procedures
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.